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Repair of DNA lesions through homologous recombination promotes the establishment
of stable chromosomal interactions. Multiple helicases, topoisomerases and structure-
selective endonucleases (SSEs) act upon recombining joint molecules (JMs) to disengage
chromosomal connections and safeguard chromosome segregation. Recent studies
on two conserved SSEs – MUS81 and Yen1/GEN1– uncovered multiple layers of
regulation that operate to carefully tailor JM-processing according to specific cellular
needs. Temporal restriction of SSE function imposes a hierarchy in pathway usage
that ensures efficient JM-processing while minimizing reciprocal exchanges between
the recombining DNAs. Whereas a conserved strategy of fine-tuning SSE functions
exists in different model systems, the precise molecular mechanisms to implement
it appear to be significantly different. Here, we summarize the current knowledge
on the cellular switches that are in place to control MUS81 and Yen1/GEN1
functions.
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Establishment and Safe Removal of DNA Joint Molecules During
Recombinational DNA Repair
In all organisms, the preservation of hereditary information relies on repair mechanisms that
counteract the lesions constantly inflicted on their DNA. Cells have matched the diversity and
complexity of these injuries with a staggering assortment of DNA repair pathways specialized in
specific types of damage. While insults like chemical modifications of the nucleotide bases and
single-strand breaks are some of themost abundant (Lindahl and Barnes, 2000), DNA double-strand
breaks (DSBs) pose a higher risk for the cell, as failure to repair them may lead to the loss of whole
chromosomal arms.
Homologous recombination (HR) is an evolutionarily conserved DSB repair pathway that resorts
to an intact DNA molecule with an identical (or nearly identical) sequence, such as the sister
chromatid or the homologous chromosome, to restore the integrity of the broken strands. For this
purpose, the HRmachinery drives the damaged DNA duplex through a series of molecular exercises
that include DNA end-resection, homology search, strand invasion and DNA synthesis to retrieve
the missing information (Heyer et al., 2010; Symington and Gautier, 2011). One central feature
of HR is that pairing and strand exchange reactions lead to the formation of increasingly stable
recombination intermediates. At the chromosomal level, these structures translate into inter-sister
(or inter-homolog) DNA joint molecules (JMs) that must be disconnected prior to cell division.
To solve this problem, cells frequently employ anti-recombinogenic helicases that dislodge the
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FIGURE 1 | DNA-centric model for JM metabolism during mitotic and
meiotic double-strand break (DSB) repair. After DNA-end resection, strand
invasion leads to the formation of joint molecules (JMs) containing displacement
loops (D-loops). Unwinding of the invading strand, mediated by Srs2, Mph1 or
RTEL1, mediates synthesis-dependent strand annealing (SDSA) and the
formation of NCO recombinants. Alternatively, capture of the second broken
DNA end, by the D-loop structure, precedes double Holliday junction formation.
The STR complex dissolves double Holliday junctions to generate NCO
recombinants. Mus81-Mms4/EME1, Slx1-Slx4, and Yen1/GEN1 resolve HJs by
endonucleolytic cleavage to generate COs and NCOs. Mlh1-Mlh3 process HJs
to generate exclusively COs. For simplicity, the roles for Sgs1 helicase in
processing early JMs and in promoting meiotic CO formation are not depicted.
invading DNA strand on displacement loop structures (D-loops;
Figure 1). However, long-lived D-loops may occasionally capture
the second broken end, which then primes DNA synthesis using
the displaced strand as a template. Sealing of the nicks at the end of
the newly synthesized strands leads to the establishment of fully
ligated four-way junctions, termed Holliday junctions (HJs; Liu
and West, 2004; Holliday, 2007). Due to the covalent nature of
the link that is formed as they mature, HJs are arguably the most
dangerous of all recombination intermediates that contribute to
the linkage of two DNA duplexes. It is important to point out
that such potentially dangerous intermediates appear not only as
a consequence of DSB repair, but also during DNA replication
(Giannattasio et al., 2014), since HR is also involved in both
replication fork reactivation and post-replicative ssDNA gap-
filling (Branzei and Foiani, 2010; Rass, 2013).
Despite the risks of interlocking the two recombining
chromosomes, the formation of JMs is crucial for HR repair both
during mitosis and meiosis. Maturation of early recombination
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intermediates into HJs withinmeiotic JMs precedes the formation
of crossovers (COs), repair products characterized by the physical
exchange of the DNA duplexes flanking the branch point
(Schwacha and Kleckner, 1995; Allers and Lichten, 2001;
Petronczki et al., 2003). Importantly, COs not only result in
the reassortment of genetic information between maternal
and paternal genomes, but are also required for the correct
bipolar segregation of homologs during the first meiotic division
(Schwacha and Kleckner, 1995; Allers and Lichten, 2001;
Petronczki et al., 2003). Since inter-homolog exchanges can lead
to loss-of-heterozygosity (LOH), mitotic cells disengage most
JMs at an early stage to prevent CO formation (Ira et al., 2003;
Bzymek et al., 2010). In addition, during the mitotic cell cycle,
removal of late JMs that contain HJs is biased toward pathways
that promote formation on non-crossover recombinants (NCOs;
Dayani et al., 2011).
So how do cells modify JM-processing according to the
specialized cellular needs of mitosis and meiosis? In order
to efficiently disengage recombination intermediates, while
having flexibility toward the choice of recombination outcome
(CO vs. NCO), cells have evolved a blend of DNA-processing
enzymes with specialized abilities (Figure 1). Helicases, such
as Srs2, Mph1/FANCM, or RTEL1, are capable of unwinding
early recombination intermediates like D-loop structures
to generate exclusively NCO recombinants (Ira et al., 2003;
Barber et al., 2008; Prakash et al., 2009). Structure-selective
endonucleases (SSEs), such as MUS81-EME1 (Mus81-Mms4 in
Saccharomyces cerevisiae; Mus81-Eme1 in Schizosaccharomyces
pombe; hereinafter, we will use the term MUS81* to refer to
all these orthologs collectively), SLX1-SLX4 (Slx1-Slx4 in S.
cerevisiae and S. pombe) and GEN1 (Yen1 in S. cerevisiae; absent
in S. pombe), can cleave late recombination intermediates,
containing HJs or HJ precursors, to generate a mixture of COs
and NCOs (Boddy et al., 2000, 2001; Kaliraman et al., 2001;
Fricke and Brill, 2003; Ip et al., 2008; Andersen et al., 2009;
Fekairi et al., 2009; Munoz et al., 2009; Svendsen et al., 2009;
Schwartz and Heyer, 2011). The STR complex (BTR in humans),
composed of the RecQ helicase Sgs1 (BLM), the topoisomerase
Top3 (TOP3a), and Rmi1 (RMI1/2), promotes the convergent
branch-migration and decatenation of double HJs to generate
NCOs (Gangloff et al., 1994; Fabre et al., 2002; Wu and Hickson,
2003). Finally, the Mlh1-Mlh3 nuclease mediates HJ processing
to generate exclusively COs through a mechanism that remains
elusive (Zakharyevich et al., 2012; Ranjha et al., 2014; Rogacheva
et al., 2014; Figure 1).
Despite the identification of specialized pathways in JM-
processing, most (perhaps all) JM-processing enzymes are
expressed and function during mitosis and meiosis. Therefore,
one key question that arises and remains largely unanswered is:
howdo cells tailor pathway usage to satisfy their specialized needs?
Recent studies focusing on MUS81* and Yen1/GEN1, two SSEs
with important roles in mitotic and meiotic DNA repair, have
started to unveil the subtle manipulations that cells utilize to tame
their potentially deleterious activities, blocking or unleashing
them according to their particular requirements. In the next
sections, we will attempt to summarize the current knowledge on
the mechanisms employed to control SSE function.
Regulation of MUS81* and Yen1/GEN1
Structure-Selective Nucleases
“Edged tools are dangerous things to handle, and not infrequently
do much hurt”
– Agnes Repplier (1855–1950)
The MUS81* Nucleases
MUS81* belongs to the XPF/Rad2 family of nucleases, whose
structural and functional features have been superbly reviewed
elsewhere (Ciccia et al., 2008). Therefore, we will only briefly
highlight some of its most relevant characteristics for our topic.
Like all the other members of the family, MUS81* exists as
a heterodimeric protein complex and harbors the distinctive
ERCC4 nuclease domain, in addition to helix-hairpin-helix
(HhH) motifs in both the N-terminal and C-terminal regions
(Figure 2). Its partner proteins (Mms4 in budding yeast, Eme1
in fission yeast, EME1 and EME2 in human cells) have a similar
domain organization, with exception of the absence of the N-
terminal HhH motif. Despite being indispensable for MUS81*
stability and the nuclease activity of the complex, Mms4, Eme1,
EME1, and EME2 are regarded as non-catalytic subunits because
they contain mutations in key residues of the ERCC4 domain.
In S. cerevisiae, mms4 mutants were initially described
by their increased sensitivity to the alkylating agent methyl
methanesulfonate (Xiao et al., 1998) and Mus81 was isolated
as a specific interactor of Rad54 in a yeast two-hybrid screen
(Interthal and Heyer, 2000). Both genes were also recovered
in a synthetic lethality screen of sgs1 mutants (Mullen et al.,
2001). In S. pombe, Mus81 was identified through a yeast two-
hybrid approach as an interactor of the checkpoint kinase Cds1
and found to exist in a complex with Eme1 (Boddy et al.,
2000, 2001). Due to its high conservation, bioinformatic analyses
succeeded in recognizing Mus81 orthologs in other organisms,
including humans (Chen et al., 2001). The strong mitotic and
meiotic phenotypes of mus81 and eme1/mms4 mutants,
including impaired DNA-damage repair, reduced spore viability
and crossover formation led to the proposal that the MUS81*
nucleases were the eukaryotic HJ resolvases (Boddy et al., 2000,
2001; de los Santos et al., 2001, 2003;Mullen et al., 2001).However,
this view was controversial since the biochemical properties of
these nucleases suggested a different resolution mechanism from
the well-established bacterial resolvase RuvC, a homodimeric
protein that introduces two symmetrical nicks in strands of like
polarity across one axis of the HJ, yielding nicked DNA duplexes
that can be ligated without the need of further processing (West,
1997; Haber and Heyer, 2001; Heyer et al., 2003; Heyer, 2004;
Hollingsworth andBrill, 2004).MUS81* complexes fromdifferent
organisms can cleave a number of different branched structures
efficiently, including 3´-flaps, D-loops, model replication forks
and nicked HJs, while intact HJs are generally poor substrates
for this nuclease (Boddy et al., 2001; Kaliraman et al., 2001;
Constantinou et al., 2002; Doe et al., 2002; Ciccia et al., 2003;
Gaillard et al., 2003; Ogrunc and Sancar, 2003; Osman et al.,
2003; Fricke et al., 2005; Gaskell et al., 2007; Ehmsen and
Heyer, 2008; Schwartz et al., 2012; Pepe and West, 2014b). Given
the broad spectrum of branched structures that the MUS81
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FIGURE 2 | Regulation of MUS81 complexes. (A) Mus81 and Mms4 from S.
cerevisiae. The residues modified in the different Mms4 mutants are depicted:
mms4-7A (S56A, S184A, S201A, S222A, S294A, T302A, S403A); mms4-np
(S55A, S56A, S184A, S201A, S221A, S222A, S301A, T302A, S403A);
mms4-14A (S55, S56, S86, S141, S184, S187, S201, S274, S291, S292,
S301, T302, S314, S403). (B) Mus81 and Eme1 from S. pombe. The residues
modified in Eme16SA are shown (S166A, S186A, S217A, S245A, S298A,
S313A) and include those in Eme14SA (S166A, S186A, S217A, S245A). (C)
Human MUS81, EME1 and EME2. Non-functional ERCC4 motifs are depicted
as white boxes. Ovals represent functional (filled) or non-functional (open) HhH
motifs. Relevant amino acid residues and the effects of particular modifications
are indicated. Close circles denote consensus sites for Cdk phosphorylation or
Cdc5 binding sites. Open circles denote phosphorylation sites. Residues in blue
have been identified as phosphosites in vivo by mass-spectrometry.
complexes can target, it was soon proposed that without strict
regulation its activity might not be beneficial and give rise to
potentially deleterious events (Kai et al., 2005). Interestingly,
recent work from different model organisms indicates that the
biological roles of the MUS81 nucleases are carefully modulated
by post-translational modifications. This allows cells to tailor
MUS81 function according to specific cellular needs, such as
boosting its ability to process JMs that have persisted until the
mitotic stage, while avoiding the unscheduled processing of other
physiologically important branched DNA structures.
S. cerevisiae Mus81-Mms4
In budding yeast, Mus81 is associated to the non-catalytic subunit
Mms4, with their main interaction domain residing in the C-
terminal region of both proteins (Fu and Xiao, 2003). It has been
found that the biochemical activity of Mus81-Mms4 fluctuates
throughout the cell cycle both in meiotic and mitotic cells, from
a minimum in G1/S to a maximum at G2/M (Matos et al.,
2011; Matos and West, 2014). As cells approach M-phase, Mms4
is increasingly phosphorylated, with a concomitant boost in
the catalytic activity of the complex (Matos et al., 2011, 2013;
Gallo-Fernandez et al., 2012; Szakal and Branzei, 2013). When
the hyperphosphorylated Mus81-Mms4 from cells in G2/M is
dephosphorylated in vitro, its nuclease activity decreases to a
basal level, indicating that biochemical hyperactivation is a direct
consequence of phosphorylation (Matos et al., 2011).
Two cell-cycle kinases have been implicated in both events: the
Polo kinase Cdc5 and M-phase Cdc28/Cdk (Matos et al., 2011,
2013; Gallo-Fernandez et al., 2012; Szakal and Branzei, 2013).
Whereas both kinase activities are required for Mus81-Mms4
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activation at the G2/M transition, Cdc5 activity seems to
be especially relevant as Cdc5 overexpression is sufficient to
drive phospho-activation outside M-phase (Matos et al., 2011,
2013). Furthermore, Cdc5 kinase is sufficient to hyperactivate
Mus81-Mms4 in vitro (Schwartz et al., 2012). However, the
precise contributions of each of these kinases to Mus81-Mms4
regulation in vivo remain to be determined: is Cdk-mediated
phosphorylation important only in priming Mms4 for Cdc5
binding, or does it also have a more direct role in the regulation of
nuclease activity?
The generation of Mms4 mutants in which Cdk/Cdc5-
dependent modification is impaired has helped us understand
the biological relevance of Mus81-Mms4 phosphorylation
(Figure 2A). In this sense, the mms4-7A (Szakal and Branzei,
2013) and mms4-np (Gallo-Fernandez et al., 2012) alleles were
created to encode substitutions of serines or threonines at
predicted Cdk (S/T-P) or Cdc5-docking (S-pS/pT-P) consensus
sites in the sequence of MMS4. An additional mutant, mms4-
14A, was engineered to prevent phosphorylation in both
predicted and in vivo-validated phosphoresidues found in
Mms4 from nocodazole-arrested cells (Matos et al., 2011). As
expected, all three mutants are largely resistant to mitosis-specific
phosphorylation (Matos et al., 2011, 2013; Gallo-Fernandez et al.,
2012; Szakal and Branzei, 2013). To assess if modification of
Mms4 could influence the catalytic properties of Mus81-Mms4,
the nuclease activities of Mus81-mms4-np and Mus81-mms4-
14A were measured in immunoprecipitates from synchronous
cells at different stages of the cell cycle. Both mutants displayed
impaired nuclease activation at the G2/M transition, consistent
with the idea that Cdc28/Cdk and Cdc5-mediated Mms4
modification is required for Mus81 hyperactivation (Matos et al.,
2011; Gallo-Fernandez et al., 2012). Although it has not been
formally tested, it is expectable that mms4-7A will manifest
similar properties.
The phenotypic analysis of mms4-7A and mms4-14A mutant
strains revealed a strong sensitivity to DNA-damaging agents
and a severe synthetic growth defect when combined with
sgs1 (Matos et al., 2011, 2013; Szakal and Branzei, 2013).
Both phenotypes are also shared with cdc5-2 mutants, which
are unable to phosphorylate and activate Mus81-Mms4 during
mitosis (Matos et al., 2013). This is in contrast to mms4-np
mutants, which show considerably milder phenotypes and only
display increased sensitivity to genotoxic agents in the absence
of sgs1 (Gallo-Fernandez et al., 2012). It is yet unclear why the
mms4-np, the mutant with an intermediate number of alanine
substitutions -nine-, has a milder phenotype than both themms4-
7A andmms4-14A alleles, but it has been proposed that differences
in the genetic backgrounds employed by each group may account
for this fact (Szakal and Branzei, 2013). Altogether, these results
indicate that hyperactivation of the Mus81-Mms4 nuclease at
G2/M is important for the elimination of those recombination
intermediates that escape the action of Sgs1.
From a mechanistic point of view, how the phosphorylation
of the nuclease drives its hyperactivation is not yet understood.
It has been proposed that Mus81-Mms4 may exist in dimeric as
well as tetrameric states in solution (Gaskell et al., 2007). This
hypothesis would provide an intuitive and elegant system for its
hyperactivation, particularly in HJ processing, which requires a
double incision for resolution of the X-shaped structure. However,
in vitro-phosphorylation experimentswith purifiedMus81-Mms4
and Cdc5, followed by size-exclusion chromatography, have ruled
out that the phosphorylation-dependent hyperactivation is a
result of multimerization of the nuclease (Schwartz et al., 2012).
An alternative possibility is that phosphorylation may lead to
changes in the stability of the complex. This seems unlikely,
though, as most of the mapped and predicted phosphorylation
sites lie outside the interaction domain between Mms4 and
Mus81, and mms4-14A seems to associate normally with Mus81
(Matos et al., 2011). Finally, phosphorylation events could trigger
a structural change that favors binding and/or turnover of the
enzyme-substrate complex. Interestingly, two phosphomimetic
mutants have been proposed to represent constitutively active
versions of the Mus81-Mms4 nuclease (mms4-56E and mms4-
56E, 184D), as their expression promotes increased CO formation
and reduced accumulation of X-shaped molecules in sgs1
mutants (Szakal and Branzei, 2013). In the future, analysis of
the biochemical properties of such mutants may contribute to
our understanding of the mechanism of Mus81-Mms4 nuclease
activation.
At the level of protein–protein interactions, it has been reported
that the binding of the N-terminal region of Mus81 and the C-
terminal region of Rad27/FEN1 results in their mutual enzymatic
stimulation (Kang et al., 2010; Thu et al., 2015). In addition,
while the human orthologs of the Mus81-Mms4 and Slx1-Slx4
can physically interact (see Human MUS81-EME1/EME2), the
initial results in budding yeast showed that these complexes
could not associate nor stimulate each other in vitro, at least
for the cleavage of different HJ substrates and model replication
forks (Schwartz et al., 2012). However, more recent work has
shown that Slx1-Slx4 can stimulate Mus81-Mms4 activity on 3´-
flap structures (Thu et al., 2015). Furthermore, phosphorylation
of the Mus81-Mms4 by Cdc5 leads to its association with the
scaffold protein Dpb11 at G2/M, which can also interact with Slx4
(Gritenaite et al., 2014). While it has not been demonstrated that
the formation of this Mus81-Mms4-Dpb11-Slx4 complex alters
the biochemical properties of Mus81-Mms4, it may provide a
system for substrate targeting, rendering Mus81 a more efficient
nuclease in vivo.
Altogether, the emerging picture is that cell cycle stage-specific
phosphorylation events are likely to modulate Mus81-Mms4
function through several complementary mechanisms: (1) direct
enhancement of nuclease activity; (2) regulation of nuclease
activity through stimulatory protein–protein interactions;
(3) regulation of protein–protein interactions that facilitate
recruitment to cognate substrates.
S. pombe Mus81-Eme1
The Mus81-Eme1 complex from fission yeast was the first
eukaryotic nuclease to be considered a nuclear HJ resolvase
(Boddy et al., 2001). Interestingly, the initial description of Mus81
as an interactor of the checkpoint kinaseCds1 (Rad53,CHK2) also
revealed thatMus81 is indeedmodified byCds1 after hydroxyurea
(HU) treatment (Boddy et al., 2000). The phosphorylation of
Mus81 at T275 (T239 in the original manuscript) is required for
Frontiers in Genetics | www.frontiersin.org July 2015 | Volume 6 | Article 2535
Blanco and Matos Regulation of MUS81 and Yen1/GEN1
its association with the phosphopeptide-binding FHA domain
in Cds1 (Kai et al., 2005). In turn, binding to Cds1 is a pre-
requisite for Mus81 hyperphosphorylation, which induces its
dissociation from chromatin without affecting nuclease activity
(Figure 2B; Kai et al., 2005). Thus, the checkpoint-mediated
modification of Mus81 is thought to prevent Mus81-dependent
cleavage of replication/recombination intermediates generated
after HU treatment (Kai et al., 2005).
Recent work has revealed a new layer of complexity in
the regulation of Mus81-Eme1. Eme1 is phosphorylated in a
Rad3 (ATR)- and Chk1 (CHK1)-dependent manner, both after
treatment with genotoxic agents and in the absence of Rqh1
(Sgs1/BLM). Interestingly, the modification of Eme1 is Cds1-
independent and causes amarked increase in the activity ofMus81
nuclease (Dehe et al., 2013). Moreover, Eme1 is also a substrate of
the cyclin-dependent kinase Cdc2 (CDK), which modifies Eme1
in a cell cycle stage-specific manner (Dehe et al., 2013).
A comparative analysis of two Eme1 mutants, one refractory
to phosphorylation events in response to camptothecin (CPT)
treatment (Eme16SA) and another carrying mutations in a
subset of four Cdc2-consensus sites within Eme16SA (Eme14SA;
Figure 2B), revealed identical consequences to Mus81-Eme1
phospho-activation: neither Eme16SA nor Eme14SA could be
phosphorylated or biochemically hyperactivated by CPT-
treatment. Consequently, the authors have suggested that
Cdc2-dependent phosphorylation is required as a priming event
for the subsequent CPT-induced modification (Dehe et al., 2013).
Recent results have shown that both the intra-S and DNA-
damage checkpoints are blind to the presence of the type
of recombination intermediates that require Mus81-Eme1 for
resolution at the onset of mitosis (Mohebi et al., 2015). Therefore,
future analyses of Mus81-Eme1 regulation will be essential to
unravel the intricate interconnections and relative contributions
of the cell cycle and the checkpoint machineries for Mus81-Eme1
activation. This is particularly relevant given the stark contrast
with the situation in budding yeast, where both physical and
genetic evidence have ruled out that the DNA-damage checkpoint
kinases like Mec1 (ATR) or Tel1 (ATM) contribute significantly
to either the phosphorylation of the Mus81-Mms4 nuclease or
the ensuing resolution of late recombination intermediates (Szakal
and Branzei, 2013).
Human MUS81-EME1/EME2
Homology-based searches using S. pombe Eme1 as a bait revealed
the existence of two partners for MUS81 in human cells,
EME1 and EME2 (Figure 2C; Ciccia et al., 2003). While both
complexes can process branchedDNA structures in vitro,MUS81-
EME2 exhibits higher nuclease activity and broader substrate
specificity (Ciccia et al., 2007; Amangyeld et al., 2014; Pepe
and West, 2014b). MUS81 and EME1 display increased levels
of phosphorylation in prometaphase nocodazole-arrested cells
compared to asynchronous, thymidine-(G1/S) or CPT-arrested
(S/G2) cells. Given the coincidence of such modifications and an
increase in the catalytic activity of MUS81 immunoprecipitates,
it was put forward that similar regulatory mechanisms might
operate to control MUS81 function in S. cerevisiae and in humans
(Matos et al., 2011).
In terms of protein–protein interactions, MUS81 is also known
to directly associate with SLX4. Together with SLX1, SLX4
constitutes a SSE with the ability to process recombination
intermediates in vitro and in vivo and serves as a landing platform
for other DNA repair factors like XPF-ERCC4 (Andersen et al.,
2009; Fekairi et al., 2009; Munoz et al., 2009; Svendsen et al., 2009;
Wechsler et al., 2011). The MUS81-SLX4 interaction is mediated
through residues within the N-terminal region (1–86) of MUS81
and the SAP domain (a putative DNA-binding region) of SLX4
and plays and important role in both general HR repair as well
as in CPT- and PARP inhibition-induced DNA damage repair
(Fekairi et al., 2009; Castor et al., 2013; Garner et al., 2013; Kim
et al., 2013). Mutations such as W24A/L25A and L66A/Q67A
in the murine ortholog of MUS81 can disrupt the interaction
with SLX4 without affecting the stability of the MUS81-EME1
complex or its nucleolytic activity on 30-flaps (Nair et al., 2014).
Likewise, the Y1340A, L1348A, and E1351A/L1352A mutations
in the SLX4 SAP domain from mice could specifically abolish the
MUS81-SLX4 interaction without disrupting the SLX4 ability to
coimmunoprecipitate SLX1 and ERCC1 (Castor et al., 2013).
Interestingly, the increase in HJ-processing activity observed in
MUS81 immunoprecipitates from cells arrested with nocodazole
is dependent on CDK activity and requires SLX4 (Wyatt et al.,
2013). SLX4, like MUS81 and EME1, is phosphorylated in a
CDK1-dependent manner and inhibition of CDK kinase activity
in nocodazole-arrested cells triggers dissociation of the complex.
Therefore, it has been suggested that the increased capability
of HJ resolution in mitotic MUS81 immunoprecipitates may
arise from the coordination of different nucleases on the SLX4
scaffold (Wyatt et al., 2013), although the molecular basis for the
CDK1-driven interaction of these two proteins remains unclear.
In this sense, biochemical experiments have shown that full-
length recombinant SLX1-SLX4 and MUS81-EME1 complexes
can interact with each other in vitro to form a more efficient
HJ resolvase. Quantitatively, the complex of the two nucleases
displays higher HJ-processing activity than the sum of both
nucleases separately, with a particular stimulation of the initial
rate of the reaction. Qualitatively, the SLX1-SLX4-MUS81-EME1
complex carries out a more coordinated HJ resolution reaction,
as judged by the increased rate of bilateral cleavage and linear
product formation in a plasmid-borne cruciform cleavage assay
(Wyatt et al., 2013). These results indicate that recruitment of
the MUS81 nuclease to the SLX4 scaffold can improve its HJ
resolution activity by coordinating its actions with those of SLX1.
Finally, another layer of complexity in the regulation of the
MUS81 nuclease arises from the existence of the non-catalytic
subunit EME2. While EME1 associates with MUS81 throughout
the cell cycle (Matos et al., 2011; Wyatt et al., 2013), the MUS81-
EME2 complex is detectable predominantly during S-phase (Pepe
and West, 2014a). Therefore, the usage of alternative non-
catalytic subunits may play a significant role in the regulation of
MUS81, with MUS81-EME2 being involved in earlier events like
replication fork restart, but not in later roles like the removal ofHJs
(Pepe and West, 2014a). We anticipate that forthcoming studies
will refine our knowledge about theMUS81 partner choice (EME1
vs. EME2) and its connection to the distinct cellular functions of
the two MUS81 complexes.
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The Yen1/GEN1 Nucleases
Human GEN1 and S. cerevisiae Yen1 are ortholog enzymes that
belong to the subclass IV of the XPG/Rad2 family of SSEs
(Johnson et al., 1998; Furukawa et al., 2003; Ip et al., 2008). Like all
the other members of this family, they contain a bipartite nuclease
domain, constituted by the XPG-N and XPG-I subdomains
connected by a poorly conserved linker region (Lieber, 1997).
While this is the main area for the interaction between the protein
and the branched DNA region, another conserved feature of the
family, the helix-two-turn-helix motif, stabilizes DNA binding
through its contactswith the duplexDNAportion of the substrates
(Tsutakawa et al., 2011, 2014). Yen1 and GEN1were characterized
as the first eukaryotic nucleases that processed HJs in a similar
manner to the archetypical bacterial RuvC HJ resolvase (Ip et al.,
2008). A recent report has shown that the two members of this
subclass IV inA. thaliana, AtGEN1 andAtSEND1, also possessHJ
resolution activity (Bauknecht and Kobbe, 2014), supporting the
hypothesis that this subclass IVof theXPG/Rad2 family comprises
a group of enzymes that have evolved HJ resolution activity
(Ip et al., 2008). Interestingly, all these HJ resolvases retain the
characteristic 5´-flap processing activity of the family, while they
can also target other replication fork-like structures (Kanai et al.,
2007; Ip et al., 2008; Rass et al., 2010; Yang et al., 2012; Bauknecht
andKobbe, 2014; Freeman et al., 2014). Therefore, aswithMUS81,
such potential for the cleavage of fully double-stranded replication
or recombination intermediates could explain why cells have
implemented mechanisms to tame these inherently dangerous
activities.
S. cerevisiae Yen1
Two distinct layers of cell-cycle stage-specific regulation
govern Yen1 function: subcellular localization and biochemical
activation. The basis for this regulation relies on changes in the
phosphorylation status of the protein, which are imposed by two
master regulators of the cell cycle: Cdc28/Cdk kinase and Cdc14
phosphatase (Blanco et al., 2014; Eissler et al., 2014; Garcia-Luis
et al., 2014). At the onset of S-phase, phosphorylation of Yen1
drives its exclusion from the nucleus, at the same time that it
inhibits its nuclease activity. When cells enter anaphase, Cdc14 is
released from the nucleolus and dephosphorylates Yen1, which
re-enters the nucleus and becomes catalytically active (Kosugi
et al., 2009; Matos et al., 2011, 2013; Blanco et al., 2014; Eissler
et al., 2014; Garcia-Luis et al., 2014).
Yen1 contains nine consensus Cdk sites (S-P, all serines),
with eight of them being full Cdk sites S-P-X-K/R. These Cdk
sites show some degree of clustering in each of the N-terminal,
central and C-terminal regions of the protein (Figure 3A), a
predictive feature of bona fide Cdk substrates (Moses et al.,
2007). Indeed, Yen1 was confirmed as a target for Cdk-dependent
phosphorylation in whole-cell extracts through proteome-wide
approaches (Ubersax et al., 2003), being a particularly good
substrate for the S-phase complexCdc28-Clb5 (Loog andMorgan,
2005). Six out of these nine Cdk sites have been verified as
phosphoresidues in vivo by mass spectrometry (Blanco et al.,
2014; Eissler et al., 2014). Additionally, four of the Cdk sites
were identified as optimal targets for Cdc14 (S500, S507, S655,
and S679) through in silico prediction and in vitro analyses of
Cdc14 activity on peptides containing these phosphoresidues
(Figure 3A; Eissler et al., 2014).
With regard to the control of Yen1 nuclease activity, it was
initially observed that the ability of Yen1 to process a HJ substrate
fluctuates throughout the cell cycle. While immunoprecipitates of
Yen1 from cells in S-phase show low levels of nuclease activity,
those from cells in mitosis can efficiently process synthetic HJs
(Matos et al., 2011). Mutation of the nine CDK consensus sites
in Yen1 to alanine results in a protein [Yen1-9A (Eissler et al.,
2014) or Yen1ON (Blanco et al., 2014)] that, as opposed to
the wild-type, (i) cannot be phosphorylated by Cdk, (ii) does
not interact with Cdc14 and (iii) displays a maximum level
of activity during all phases of the cell cycle, bypassing the
requirement for Cdc14 for its activation. A partial dissection
of the relative contribution of the different Cdk sites to this
regulation has shown that serine to alanine mutations in the C-
terminal cluster (S655 and S679) have no effect on the biochemical
activity of Yen1 and, so far, the significance of the potential
phosphorylation events on the N-terminal cluster remains poorly
defined. However, phosphorylation-resistant mutants in the four
serines of the central cluster (S500, S507, S513, and S583) result in
a protein that is no longer inhibited during S-phase and displays
increased levels of crossover formation (Blanco et al., 2014; Eissler
et al., 2014). Conversely, expression of a phosphomimetic mutant
for these residues phenocopies the deletion of YEN1 (Eissler
et al., 2014). Since phosphorylation-dependent inhibition of Yen1
nuclease activity derives from a reduction in its substrate binding
affinity (Blanco et al., 2014), the central cluster may be part
of a repressible DNA binding domain or serve as a switch for
a conformational change between low- and high-DNA binding
forms of Yen1.
Concerning the spatial regulation of Yen1, the changes in its
localization are related to the phosphorylation status of the CDK
target site S679. This serine in the C-terminal cluster overlaps with
a predicted nuclear localization signal (NLS; 679-SPIKKSRTT-
687). Immunofluorescence analysis of overexpressed, GFP-tagged
Yen1 revealed that the mutation of S679 to alanine led to
permanent nuclear accumulation (Kosugi et al., 2009). A more
detailed analysis showed that phosphorylation of other CDK
sites may also influence Yen1 localization. The proportion of
nuclear Yen1 was shown to be higher with Yen1ON than with
Yen1S679A mutants (Blanco et al., 2014). Therefore, it has been
suggested that the NLS in Yen1 may be bipartite and controlled
by the phosphorylation of two different CDK sites, S655, and
S679 (Eissler et al., 2014). In addition, the observation that Msn5,
a karyopherin involved in the nuclear export of phosphorylated
proteins, is responsible for Yen1 export (Kosugi et al., 2009),
suggests that the phosphorylation status of CDK sites overlapping
yet-unidentified nuclear export signals may also influence its
localization.
The expression of Yen1ON/Yen1-9A, which bypasses the
two levels of Cdk-dependent control, has demonstrated the
importance of restricting Yen1 function prior to anaphase for
the maintenance of genome stability. Premature activation of
Yen1 leads to increased DNA-damage sensitivity, crossover
formation and loss of heterozygosity in diploid cells (Blanco
et al., 2014; Eissler et al., 2014). Incidentally, Yen1ON can
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FIGURE 3 | Regulation of Yen1/GEN1. (A) S. cerevisiae Yen1. Yen1
NLS has been traditionally considered monopartite (orange oval),
although Eissler et al. (2014) have recently proposed it could be
bipartite (extending to the dashed oval area). All the Cdk sites are
indicated. (B) Human GEN1. All the CDK sites are indicated. Key as in
Figure 1.
suppress the synthetic lethality ofmus81 sgs1 double mutants,
thus demonstrating that the premature activation of Yen1 can
compensate for the loss of other genes involved in the processing
of recombination intermediates (Blanco et al., 2014).
Human GEN1
Soon after its identification, several lines of evidence pointed
toward proteolytic cleavage as a putative mechanism to regulate
GEN1 activity through the excision of a self-inhibitory domain
in the long, unstructured C-terminal region of the protein (Ip
et al., 2008; Rass et al., 2010). Both the 60 kD N-terminal
fragment originally identified by mass spectrometry of highly
fractionated HeLa extracts and the recombinant GEN11–527
truncation fragment exhibited increased biochemical activity
compared to the full-length protein (Ip et al., 2008). Moreover,
GEN11–527 was able to partially suppress the DNA damage
sensitivity and meiotic crossover defects of fission yeast strains
deficient for either Mus81 or Rqh1 (Sgs1 in budding yeast, BLM
in mammalians; Lorenz et al., 2010). However, there is no definite
evidence so far for the C-terminal region cleavage as an activation
mechanism for GEN1 in vivo.
On the other hand, the sequence of GEN1 contains eight
CDK consensus target sites, a number similar to those in Yen1,
although their relative position and context is not conserved
(Figure 3B). This suggested that a similar CDK phosphorylation-
dependent regulatory mechanism could operate for Yen1 and
GEN1 (Matos et al., 2011). It has been recently shown that
GEN1 is indeed phosphorylated in a seemingly CDK-dependent
manner, as mutation of all the serines/threonines in its consensus
CDK targets (GEN18A) abolishes virtually all the slowlymigrating
forms of the protein (Chan and West, 2014). However, changes
in the phosphorylation status of the protein do not affect its
nuclease activity as dramatically as in the case of Yen1, since
both GEN18A and in vitro dephosphorylated GEN1 retain the
wild-type ability to process HJs (Matos et al., 2011; Chan and
West, 2014). Therefore, it appears unlikely that the control of the
biological functions of GEN1 relies on the direct modulation of
its nucleolytic activity. Instead, localization studies have suggested
that human cells restrict the actions of this nuclease through
its temporal exclusion from the nucleus. GEN1 is strongly
enriched in the cytoplasm during interphase, gaining access to
chromatin in prometaphase, only after the nuclear envelope has
broken down (Matos et al., 2011). The subcellular localization
pattern of GEN1 appears to be exclusively dependent on a
nuclear export signal that has been recently identified in its
unstructured C-terminal region (660-LLSGITDLCL-669; Chan
and West, 2014).
To demonstrate the importance of the restriction of GEN1
access to the nucleus prior to mitosis, a constitutively nuclear
version of the enzyme, GEN1nuc, was generated by adding
three copies of a SV40-derived NLS at its C-terminus and
by mutating four key hydrophobic residues in GEN1 NES to
alanine (L660A, L661A, I664A, L667A). When introduced in
cells, GEN1nuc induces a series of phenotypes that are partially
reminiscent of those observed in yeast expressing mis-regulated
Yen1. For instance, GEN1nuc expression increases the occurrence
of sister chromatid exchanges (COs). Also, it can reduce the
defects associated with the double depletion of MUS81 and
BLM, resulting in increased cellular viability and reduction
of chromosomal breaks (Chan and West, 2014). However, no
increased sensitivity to DNA-damaging agents was observed in
cells expressing GEN1nuc. This could reflect a differential ability
betweenYen1 andGEN1 to process branchedDNA structures that
are generated in vivo during active replication, stalled replication
fork repair/restart or the early steps of homologous recombination
(Blanco et al., 2014; Chan and West, 2014).
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Concluding Remarks
Traditional models of homologous recombination based on a
DNA substrate-centric view of JM-processing (e.g., Figure 1) are
insufficient to explain how cells control the outcome of DNA
repair. In such models, enzymes are positioned according to their
in vitro substrate preference, which is difficult to reconcile with
their rather promiscuous biochemical properties and intricate
genetic relationships. Work on the regulation of MUS81* and
Yen1/GEN1 nucleases has introduced a new dimension to such
models, a dimension in which defined cellular circumstances
strongly influence pathway usage. However, despite the recent
advances summarized here, there are still fundamental questions
concerning SSE regulation that remain unanswered. For instance,
we have just begun to comprehend the mechanistic basis for the
control of the catalytic properties of SSEs by post-translational
modifications. Therefore, we will need detailed biochemical
and structural information to help us understand how similar
phosphorylation events translate into opposite responses from
each protein.
The ability to turn on and off JM-processing enzymes at a given
cell cycle stage, or upon the cellular detection of a given stimulus,
seems an efficient mechanism to bias the choice toward the most
suitable DNA repair pathway and could potentially control the
function of repair enzymes other than MUS81* and Yen1/GEN1.
It is therefore tempting to envisage that in addition to developing
enzymes capable of processing a specialized, but overlapping
range of DNA substrates, cells have evolved the general ability
to regulate their actions. Such combination of capacities would
prevent pathway competition as well as the toxic processing of
vital endogenous DNA structures. Furthermore, it would allow
for the flexible implementation of pathway usage according to the
chromosome segregation programs of meiosis and mitosis.
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